Barclays’s Vitamin Cottage Natural Grocers NGVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$290K Sell
11,214
-24,146
-68% -$624K ﹤0.01% 3489
2025
Q4
$886K Sell
35,360
-22,889
-39% -$733K ﹤0.01% 3518
2025
Q3
$2.33M Buy
58,249
+34,098
+141% +$1.32M ﹤0.01% 2776
2025
Q2
$948K Buy
24,151
+12,700
+111% +$588K ﹤0.01% 3372
2025
Q1
$460K Sell
11,451
-2,773
-19% -$116K ﹤0.01% 3579
2024
Q4
$565K Buy
14,224
+1,804
+15% +$62.4K ﹤0.01% 3752
2024
Q3
$369K Buy
12,420
+9,196
+285% +$233K ﹤0.01% 3956
2024
Q2
$68.3K Sell
3,224
-3,300
-51% -$62.8K ﹤0.01% 4082
2024
Q1
$118K Sell
6,524
-16,010
-71% -$257K ﹤0.01% 4378
2023
Q4
$361K Buy
22,534
+11,604
+106% +$169K ﹤0.01% 4086
2023
Q3
$141K Sell
10,930
-175
-2% -$2.23K ﹤0.01% 3446
2023
Q2
$136K Sell
11,105
-2,871
-21% -$32.3K ﹤0.01% 3426
2023
Q1
$164K Buy
13,976
+2,242
+19% +$23.2K ﹤0.01% 3909
2022
Q4
$107K Buy
11,734
+2,097
+22% +$22.1K ﹤0.01% 4184
2022
Q3
$104K Sell
9,637
-72
-0.7% -$1.07K ﹤0.01% 3530
2022
Q2
$154K Sell
9,709
-3,139
-24% -$58.4K ﹤0.01% 3572
2022
Q1
$251K Sell
12,848
-9,696
-43% -$161K ﹤0.01% 3280
2021
Q4
$321K Buy
22,544
+18,774
+498% +$241K ﹤0.01% 3388
2021
Q3
$42K Buy
3,770
+2,602
+223% +$28.9K ﹤0.01% 4147
2021
Q2
$12K Sell
1,168
-6,456
-85% -$87.4K ﹤0.01% 4596
2021
Q1
$134K Buy
7,624
+4,680
+159% +$73.9K ﹤0.01% 3882
2020
Q4
$41K Sell
2,944
-7,185
-71% -$89.4K ﹤0.01% 4493
2020
Q3
$99K Sell
10,129
-832
-8% -$10.9K ﹤0.01% 4262
2020
Q2
$163K Buy
10,961
+4,771
+77% +$58.1K ﹤0.01% 4215
2020
Q1
$52K Sell
6,190
-3,047
-33% -$26.2K ﹤0.01% 5209
2019
Q4
$91K Buy
9,237
+4,578
+98% +$42K ﹤0.01% 5520
2019
Q3
$46K Sell
4,659
-2,346
-33% -$23.3K ﹤0.01% 5948
2019
Q2
$71K Sell
7,005
-77,869
-92% -$892K ﹤0.01% 5917
2019
Q1
$1.01M Buy
84,874
+47,018
+124% +$665K ﹤0.01% 3386
2018
Q4
$581K Sell
37,856
-24,118
-39% -$426K ﹤0.01% 3675
2018
Q3
$1.05M Buy
61,974
+60,443
+3,948% +$1M ﹤0.01% 3575
2018
Q2
$19K Sell
1,531
-337
-18% -$3.25K ﹤0.01% 6218
2018
Q1
$14K Buy
1,868
+407
+28% +$3.12K ﹤0.01% 6556
2017
Q4
$13K Buy
1,461
+1,046
+252% +$6.88K ﹤0.01% 6451
2017
Q3
$2K Sell
415
-701
-63% -$4.69K ﹤0.01% 6678
2017
Q2
$9K Sell
1,116
-2,448
-69% -$24.1K ﹤0.01% 6086
2017
Q1
$36K Buy
3,564
+2,752
+339% +$32.8K ﹤0.01% 5516
2016
Q4
$9K Sell
812
-2,053
-72% -$24.4K ﹤0.01% 5940
2016
Q3
$32K Buy
2,865
+1,506
+111% +$18.6K ﹤0.01% 5239
2016
Q2
$18K Buy
+1,359
New +$20.1K ﹤0.01% 5318
2015
Q4
Sell
-46
Closed -$1K 6375
2015
Q3
$1K Sell
46
-126
-73% -$3.03K ﹤0.01% 6568
2015
Q2
$4K Sell
172
-98
-36% -$2.51K ﹤0.01% 6564
2015
Q1
$7K Sell
270
-1,206
-82% -$34.3K ﹤0.01% 6434
2014
Q4
$41K Buy
1,476
+1,164
+373% +$24.2K ﹤0.01% 5864
2014
Q3
$4K Sell
312
-6,897
-96% -$139K ﹤0.01% 7245
2014
Q2
$151K Buy
7,209
+4,695
+187% +$129K ﹤0.01% 5100
2014
Q1
$108K Buy
2,514
+2,019
+408% +$82.3K ﹤0.01% 5378
2013
Q4
$21K Buy
495
+163
+49% +$6.28K ﹤0.01% 6689
2013
Q3
$13K Sell
332
-128
-28% -$4.68K ﹤0.01% 6699
2013
Q2
$14K Buy
+460
New +$12.5K ﹤0.01% 6990

Other funds holding NGVC

Barclays's NGVC Position: Q1 2026 in Review

Barclays reduced its Vitamin Cottage Natural Grocers (NGVC) stake by 68% in Q1 2026, selling an estimated $624K and leaving 11,214 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #3489.

Barclays first reported a position in NGVC in Q2 2013 and has held it in 50 quarters since. The position peaked at $2.33M in Q3 2025. 155 funds tracked by Wall St. Rank hold NGVC as of Q1 2026.

  • Barclays held 11,214 shares of Vitamin Cottage Natural Grocers worth $290K as of Q1 2026.
  • Barclays sold 24,146 Vitamin Cottage Natural Grocers shares in Q1 2026, an estimated $624K.
  • Vitamin Cottage Natural Grocers made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3489 holding.
  • Barclays first reported a position in Vitamin Cottage Natural Grocers in Q2 2013 and has held it in 50 quarters since.
  • Barclays's Vitamin Cottage Natural Grocers position peaked at $2.33M in Q3 2025.
  • 155 funds tracked by Wall St. Rank held Vitamin Cottage Natural Grocers as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.